Expression of the low-density lipoprotein receptor, HMG-CoA reductase, and multidrug resistance (Mdr1) genes in colorectal carcinomas.
暂无分享,去创建一个
[1] S. Vitols,et al. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia , 1995, Medical oncology.
[2] G. Juliusson,et al. Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy- 3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells , 1994 .
[3] G. Giaccone,et al. Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] W. Scheithauer,et al. MDR1 gene expression in primary colorectal carcinomas. , 1993, British Journal of Cancer.
[5] O. Larsson,et al. Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo. , 1992, Cancer research.
[6] R. Zittoun,et al. Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. , 1992, Leukemia.
[7] H. Luthman,et al. Quantitative determination of mdrl gene expression in leukaemic cells from patients with acute leukaemia , 2007 .
[8] S. Bates,et al. Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines. , 1992, Journal of the National Cancer Institute.
[9] C. Seynaeve,et al. A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance. , 1991, British Journal of Cancer.
[10] G. Margison,et al. Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors. , 1991, Cancer research.
[11] T. Tsuruo,et al. Expression of the MDR1 gene in human gastric and colorectal carcinomas. , 1990, Journal of the National Cancer Institute.
[12] S. Vitols,et al. Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex. , 1990, British Journal of Cancer.
[13] K. Einarsson,et al. Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[14] G. Gahrton,et al. Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[15] V. Ling,et al. P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines. , 1989, Cancer research.
[16] I. Pastan,et al. Expression of Multidrug Resistance Gene in Human Cancers , 1989 .
[17] M. Nakanishi,et al. Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. , 1988, The Journal of biological chemistry.
[18] I. Pastan,et al. The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. , 1987, The Journal of biological chemistry.
[19] I. Pastan,et al. Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene , 1986, Molecular and cellular biology.
[20] D. Housman,et al. Isolation and expression of a complementary DNA that confers multidrug resistance , 1986, Nature.
[21] I. Pastan,et al. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. , 1986, Science.
[22] M. Brown,et al. A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.
[23] G. Gahrton,et al. HYPOCHOLESTEROLAEMIA IN MALIGNANCY DUE TO ELEVATED LOW-DENSITY-LIPOPROTEIN-RECEPTOR ACTIVITY IN TUMOUR CELLS: EVIDENCE FROM STUDIES IN PATIENTS WITH LEUKAEMIA , 1985, The Lancet.
[24] G. Canti,et al. In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice. , 1984, Cancer letters.
[25] C. McArdle,et al. Low-density lipoprotein metabolism in mice with soft tissue tumours. , 1984, Biochimica et biophysica acta.
[26] R. Palmiter,et al. A practical approach for quantitating specific mRNAs by solution hybridization. , 1983, Analytical biochemistry.
[27] P. Tartter,et al. Serum cholesterol and human colon cancer. , 1981, Journal of the National Cancer Institute.
[28] K. Paigen,et al. A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.
[29] M. Brown,et al. Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. , 1978, Blood.
[30] R L Juliano,et al. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.
[31] B. Efron,et al. The possible prognostic usefulness of assessing serum proteins and cholesterol in malignancy , 1975, Cancer.
[32] E. Bjelke. COLON CANCER AND BLOOD-CHOLESTEROL , 1974 .
[33] M. Lockshin,et al. Letter: Lymphocyte response. , 1974, Lancet.
[34] W. Kannel,et al. Colon cancer and blood-cholesterol. , 1974, Lancet.
[35] K. Danø. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. , 1973, Biochimica et biophysica acta.
[36] I. Pastan,et al. Expression of the Multidrug Resistance Gene in Human Cancer , 1991 .
[37] I. Pastan,et al. Expression of a multidrug-resistance gene in human tumors and tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[38] V. Ling,et al. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies , 1985, Nature.
[39] C. Lamers,et al. Letter: Streptozotocin in the Zollinger-Ellison syndrome. , 1975, Lancet.